18.5 C
New York
Thursday, June 4, 2026

Tag: 3

Mammotome Expands Access to Innovative Breast Biopsy Site Marker

Securing this CE mark expands access to the HydroMARK™ Plus markers across Europe, combining proprietary hydrogel technology with features designed to support marker stability...

Teacher confidence in AI grows, but call for more training to prepare students

LONDON, June 4, 2026 /PRNewswire/ -- New research from Pearson (FTSE: PSON.L), the world's lifelong learning company, suggests that UK teachers' confidence in using AI...

Share Buyback Transaction Details May 28 – June 3, 2026

PRESS RELEASE                                        

Leetx Unveils 2026 European Roadshow, Bringing Full-Range Industrial Assembly Technology Closer to EU Manufacturers

Five-stop trade show roadmap across Germany, Spain and Poland to showcase transducerized tightening, servo pressing, automated screw feeding and precision dispensing solutionsMUNICH, June 4,...

AbolerIS Pharma Presents New Data Supporting CD45RC as a Novel Therapeutic Target and Potential Biomarker in Sjögren’s Disease at EULAR 2026

- Findings demonstrate strong correlation between CD45RC expression and lymphocytic infiltration in salivary glands, supporting its potential as both an early biomarker and therapeutic...

sim Credit Card Fully Supports the 2026 Global Football Event

Launching the "2026 World Class Offers"HONG KONG, June 4, 2026 /PRNewswire/ -- The quadrennial global football event is about to get the whole world...

【COMPUTEX 2026】Compal Integrates Quantum Technology and AI – Partnering with Top Universities and Pharmaceutical Firms to Build a Biotech AI Platform

TAIPEI, June 4, 2026 /PRNewswire/ -- Compal Electronics (Compal; TWSE: 2324) showcases its landmark achievements in Quantum Technology and Advanced Artificial Intelligence (AI) at COMPUTEX...

“Go AI Native with MuleRun” Lights Up New York Tech Week

NEW YORK, June 4, 2026 /CNW/ -- As part of New York Tech Week, MuleRun successfully hosted "Go AI Native with MuleRun – Key...

EULAR 2026: Dapirolizumab Pegol Shows Potential to Reduce Flare Rates and Maintain Disease Control in Systemic Lupus Erythematosus

BRUSSELS, Belgium and CAMBRIDGE, Mass., June 04, 2026 (GLOBE NEWSWIRE) -- UCB (Euronext Brussels: UCB) and Biogen Inc. (Nasdaq: BIIB) today announced data, comprising two posters and three abstracts, at the European Alliance of Associations for Rheumatology (EULAR) 2026 Congress, demonstrating the clinical profile of dapirolizumab pegol (DZP), an investigational biologic in patients with systemic lupus erythematosus (SLE).

Sunshine Silver Mining & Refining Announces Pricing of Initial Public Offering

KELLOGG, Idaho, June 3, 2026 /PRNewswire/ -- Sunshine Silver Mining & Refining Company (the "Company" or "Sunshine") today announced the pricing of its initial...

Bell Announces Upsizing and Results of its Cash Tender Offers for Debt Securities

This news release contains forward-looking statements. For a description of the related risk factors and assumptions, please see the section entitled "Caution Concerning Forward-Looking...

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Graphic Packaging Holding Company Investors to Secure Counsel Before Important Deadline in Securities Class Action –...

NEW YORK, June 03, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Graphic Packaging Holding Company (NYSE: GPK) between February 4, 2025 and February 2, 2026, inclusive (the “Class Period”), of the important July 6, 2026 lead plaintiff deadline.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTags3